When [OGS Mechanics] got a Mercedes EQC 300 battery-electric car in for repair, it was found to have a bit of a weird issue: ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

Bristol Myers Squibb (NYSE: BMY; BMS) delivered some good news to investors in reporting fourth-quarter and full-year 2025 results on Thursday. The pharma giant beat analyst consensus forecasts by ...

Some members of the maker community are distraught about Arduino’s new terms of service (ToS), saying that the added rules put the company’s open source DNA at ...

The future of electric vehicles depends on battery packs that are safe, efficient, and easy to maintain. Wireless battery-management systems introduce a new way to cover all of these needs. What’s the ...

Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...

Nearly 4,500 Tesla Model 3 and Model Y owners in South Korea have complained about battery malfunctions that prevent charging. The problem, which primarily affects 2021 models, has drawn the scrutiny ...

In a deal that surprised some industry observers, chipmaker Qualcomm has agreed to buy Arduino, which is best known for supplying microcontrollers to the DIY community. The acquisition, whose terms ...

Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...

Sigvotatug vedotin (SV), an investigational integrin beta-6 (IB6)–directed antibody‒drug conjugate (ADC), and pembrolizumab combination therapy: Initial results from an ongoing phase 1 study ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...